Beijing Scrianen Pharmaceutical Co., Ltd. Successfully Attends CPHI Milan 2026

     Beijing Scrianen Pharmaceutical Co., Ltd. recently completed its official participation in CPHI Milan, one of the world’s most influential international exhibitions for the pharmaceutical industry, held in Milan, Italy.

appearance marked an important step for the company to further expand its global presence in the API and finished drug sectors.

   During the exhibition, the Beijing-based pharmaceutical enterprise showcased its core product portfolio, with a special focus on its high-quality protamine sulfate API and related injectable preparations. The company’s on-site technical and business teams engaged in in-depth exchanges with global raw material suppliers, finished drug manufacturers, distributors and regulatory consultants from more than 30 countries and regions.

    CPHI Milan, as a leading global platform for the pharmaceutical supply chain, creates direct opportunities for industry participants to discuss GMP-compliant production processes, international registration pathways, and stable supply cooperation under increasingly strict global quality standards. Many visiting partners expressed strong interest in Scrianen’s consistent quality control system and its ongoing efforts to meet both ICH and local market regulatory requirements.

   “Taking part in CPHI Milan allows us to move beyond traditional regional cooperation and connect face-to-face with partners who value reliable, traceable pharmaceutical supply,” the company’s international business representative stated on site. “We see this exhibition not only as a showcase of our existing product capacity, but also as a starting point for long-term, transparent collaboration in the global pharmaceutical market.”

Through this event, Beijing Scrianen Pharmaceutical has further consolidated its understanding of the European and Mediterranean pharmaceutical markets, collected first-hand industry feedback, and laid a more solid foundation for future international registration, cross-border technical cooperation and sustainable global business layout.